This study tested the hypothesis that combined adipose-derived mesenchymal stem cell (ADMSC) and low-energy extracorporeal shock wave (ECSW) therapy could protect brain from brain death (BD)-induced injury. Adult male Sprague Dawley rats were catego-
INTRODUCTION
Despite advancements in pharmaceuticals, supportive mechanical devices, nutritional and life style improvements, and renewed clinical guidelines, decompensated congestive heart failure remains a major cause of cardiovascular deaths worldwide (1) (2) (3) (4) (5) (6) (7) . Heart transplantation is a final resort for patients with severe advanced congestive heart failure who are refractory to optimal management (8) (9) (10) (11) . However, aside from life-long use of immunosuppressant drugs, heart transplantation faces 2 important problems: (1) shortage of donors and (2) graft-versus-host disease leading to acute and chronic transplant rejection. Curtailment of graft-versus-host disease is increasingly effective with modern immunosuppressant regimens in most recipients. However, only organ donors with brain death (BD) supply hearts for transplantation, limiting the number of available donor hearts.
BD commonly elicits remote organ damage (i.e. liver, lung, and heart) and both experimental and clinical studies (12) (13) (14) (15) have revealed that $25% of patients have lower left ventricular function even at the early stage of BD (16) (17) (18) (19) (20) . Intriguingly, the underlying mechanism of BD-induced remote organ damage has been investigated and found mainly due to vigorously acute inflammatory and immune reactions (17) (18) (19) (20) (21) . Accordingly, we propose that inhibiting BD-elicited inflammatory immune reactions in brain tissue and in circulation could play a crucial role in reducing BD-induced remote organ damage.
Plentiful data have shown that mesenchymal stem cells (MSCs), especially adipose-derived MSCs (ADMSCs), have tissue regeneration, anti-inflammatory (22, 23) and immunomodulatory capacities (20, 24, 25) . Additionally, our recent work has demonstrated that ADMSC therapy protected remote organs against BD-induced injury (20) . Furthermore, a body of work has demonstrated that extracorporeal shock wave (ECSW) therapy has strong capacity for anti-inflammation, suppressing oxidative stress generation, upregulating endogenous nitric oxide production, and enhancing angiogenesis (26) (27) (28) . Interestingly, our previous study showed that low energy ECSW therapy effectively preserved neurological function in rodent after acute ischemic stroke (29) . Accordingly, we tested the hypothesis that combined ADMSC and low-energy ECSW might offer an additional benefit for protecting the brain from BD-induced injury.
MATERIALS AND METHODS

Ethics
All animal procedures were approved by the Institute of Animal Care and Use Committee at Kaohsiung Chang Gung Memorial Hospital (Affidavit of Approval of Animal Use 
Induction of BD in the Animal Model
The procedure and protocol of BD induction has previously been reported (20) . For BD induction, animals in each group were anesthetized by inhalation of 2.0% isoflurane on a warming pad (37 C) and placed prone. The model mimics the clinical setting of sudden-onset increase in intracranial pressure as in severe traumatic intracranial hemorrhage that results in brainstem failure. Through a full thickness scalp incision, a burr hole was placed at the paramedian space near the frontal transverse sinus using a dental drill and a 4F angioplasty balloon catheter was introduced into the supradural space. Animals in each group were endotracheally intubated with positive-pressure ventilation (180 mL/minute) with room air using a small animal ventilator (SAR-830/A, CWE, Inc., Ardmore, PA) at a ventilation rate of $60/minute and BD was induced by injecting 0.5 mL of distilled water through the catheter into the supradural balloon. Heart rate and blood pressure were continuously monitored. The criteria for BD in animals in the present study was identical to that previously reported (20) .
Animal Grouping in the Present Study
Pathogen-free, adult male Sprague Dawley rats (n ¼ 30) weighing 325-350 g (Charles River Technology, BioLASCO, Taiwan) were utilized in the present study. The animals were randomly divided into 5 groups: Sham-operated control (SC) (i.e. only received a scalp incision, followed by closure of the wound); BD; BD þ ECSW (0.15 mJ/mm 2 /300 impulses applied to skull surface 3 hours after BD induction); BD þ allogenic ADMSC ([1.2 Â 10
6 cell] by intravenous injection 3 hours after BD induction); and BD þ ECSW þ allogenic ADMSC. All animals were killed and their brains harvested immediately by 6 hours after BD induction for individual study.
Isolation of Adipose Tissue From an Additional 12 Animals for Culturing ADMSCs
The procedure and protocol for ADMSC isolation and culturing have been described in our previous reports (30, 31) . Briefly, additional 12 animals were anesthetized with inhalational 2.0% isoflurane 14 days before BD induction to harvest adipose tissue surrounding the epididymis. Then 200-300 lL of sterile saline was added to every 0.5 g of adipose tissue to prevent dehydration. The tissue was cut into <1 mm 3 size pieces using a pair of sharp, sterile surgical scissors. Sterile saline (37 C) was added to the homogenized adipose tissue at a ratio of 3:1 (saline:adipose tissue) by volume. Isolated allogenic ADMSCs were cultured in a 100-mm-diameter dish with 10 mL DMEM culture medium containing 10% FBS for 14 days.
Collection of Circulating and Splenic Blood Samples
Blood samples were collected at 6 hours after BD induction to measure circulating immune (CD3/CD4þ, CD8/ CD4þ, Tregþ) and inflammatory (Ly6Gþ, CD11b/cþ, and myeloperoxidase [MPO]þ) cells and inflammatory biomarkers by flow cytometry. Additionally, blood samples were collected from the spleen prior to death for analysis of immune cells (CD3/CD4þ, CD8/CD4þ, Tregþ).
Flow Cytometric Quantification of Helper T Cells, Cytotoxic T Cells, and Circulatory Inflammatory Cells
The procedure and protocol of flow cytometry for identification and quantification of circulating and splenic immune cells were based on our previous report (32) . Briefly, the peripheral blood mononuclear cells and splenocytes were obtained from the tail vein using a 27-gauge needle. 
Immunohistochemical (IHC) and Immunofluorescent (IF) Staining
The procedure and protocol of IF staining have been detailed in our previous reports (20, 22, 23) . For IHC and IF staining, rehydrated paraffin sections were first treated with 
Western Blot Analysis
The procedure and protocol for Western blot analysis were based on our recent reports (20, 22, 23) . Equal amounts (50 lg) of protein extracts were loaded and separated by SDS-PAGE using acrylamide gradients. After electrophoresis, the separated proteins were transferred electrophoretically to a polyvinylidene difluoride (PVDF) membrane (Amersham Biosciences, Little Chalfont, UK). Nonspecific sites were blocked by incubation of the membrane in blocking buffer (5% nonfat dry milk in T-TBS [TBS containing 0.05% Tween 20] was used as a secondary antibody for 1-hour incubation at room temperature. The washing procedure was repeated 8 times within 1 hour. Immunoreactive bands were visualized by enhanced chemiluminescence ([ECL] Amersham Biosciences) and exposed to Biomax L film (Kodak). For the purpose of quantification, ECL signals were digitized using Labwork software (UVP).
Oxidative Stress Reaction in BD Tissue
The procedure and protocol for assessing protein expression of oxidative stress have been described previously (20, 22, 23) . The Oxyblot Oxidized Protein Detection Kit was purchased from Chemicon (Burlington, MA) (S7150). DNPH derivatization was performed on 6 lg of protein for 15 minutes according to the manufacturer's instructions. One-dimensional electrophoresis was performed on 12% SDS/polyacrylamide gel after DNPH derivatization. Proteins were transferred to nitrocellulose membranes which were then incubated in primary antibody solution (antiDNP 1:150) for 2 hours, followed by incubation in secondary antibody solution (1:300) for 1 hour at room temperature. The washing procedure was repeated 8 times within 40 minutes. Immunoreactive bands were visualized by ECL (Amersham Biosciences) and then exposed to Biomax L film (Kodak). For quantification, ECL signals were digitized using Labwork software (UVP). For oxyblot protein analysis, a standard control was loaded on each gel.
Statistical Analysis
Quantitative data are expressed as means 6 SD. Statistical analysis was adequately performed by ANOVA followed by Bonferroni multiple comparison procedure. Statistical analysis was performed using SAS statistical software for Windows version 13 (SAS Institute, Cary, NC). A probability value <0.05 was considered statistically significant.
RESULTS
Flow Cytometric Analysis of Circulating and Splenic Levels of Immune Cells, and Circulating Levels of Inflammatory Cells at 6 Hours After BD Induction
Flow cytometric results showed that circulating and splenic levels of CD3þ/CD4þ and CD3þ/CD8þ cells, 2 indicators of immune cells, were highest in BD, lowest in SC, significantly lower in BD þ ECSW þ ADMSC than in BD-ECSW and BD þ ADMSC, and significantly lower in BD þ ECSW than in BD þ ADMSC, whereas the circulating and splenic levels of Tregþ cells, an immune regulatory T cell, displayed an opposite pattern to that CD3þ/CD4þ cells among the 5 groups (Fig. 1) . The circulating levels of CD11b/ cþ, LyG6þ, and MPOþ cells, 3 indicators of inflammatory cells exhibited an identical pattern to CD3þ/CD4þ cells among the 5 groups (Fig. 2) .
ECSW-ADMSC Therapy Attenuated Oxidative Stress in Brain Damaged Area by 6 Hours After BD
The protein expressions of NOX-1, NOX-2, and oxidized protein, 3 indicators of oxidative stress, were lowest in SC and significantly progressively reduced from BD to BD þ ECSW þ ADMSC groups (Fig. 3) .
ECSW-ADMSC Therapy Ameliorated Inflammatory Biomarkers in Brain Damaged Area by 6 Hours After BD
Protein expressions of TNF-1a, NF-jB, IL-1b, TLR-2, and TLR-4, 5 indicators of inflammation, were lowest in SC and significantly progressively decreased from BD to BD þ ECSW þ ADMSC groups (Fig. 4) . 
ECSW-ADMSC Therapy Alleviated Apoptosis and DNA and Mitochondrial Damage Biomarkers in Brain Damaged Area by 6 Hours After BD
Protein expressions of mitochondrial Bax, cleaved caspase 3 and cleaved PARP, 3 indicators of apoptosis, were lowest in SC and significantly progressively decreased from BD to BD þ ECSW þ ADMSC groups. Additionally, protein expression of c-H2AX, a DNA-damage indicator and protein expression of cytosolic cytochrome C, a mitochondrial damage marker, exhibited an identical pattern of apoptosis among the 5 groups, whereas the protein expression of mitochondrial cytochrome C, an indicator of mitochondrial integrity, exhibited an opposite pattern to that of apoptosis (Fig. 5) . (20, 29) , was significantly highest in SC, lowest in BD alone, significantly lower in BD þ ECSW than in BD þ ADMSC and BD þ ECSW þ ADMSC therapy, but showed no differences between the latter 2 groups (Fig. 6) .
The protein expression of SITR3, another antioxidant indicator (20, 29) , was highest in SC and significantly progressively increased from BD to BD þ ECSW þ ADMSC. The protein expressions of HMGB1, a component of inflammatory damage-associated molecular pattern that always released from brain tissue after brain damage to elicit the downstream inflammatory signaling pathway, such as TRL2/TRL4, MyD88, and TNF-a, an indicator of inflammation (20, 29) , displayed an opposite pattern of SIRT3 among the 5 groups. Additionally, the protein expression of MyD88, the downstream signaling of HMGB1, exhibited an identical pattern to that of HMGB1 among the 5 groups. (20, 29) , were lowest in SC, highest in BD, significantly higher in BD þ ECSW than in BD þ ADMSC and BD þ ECSW þ ADMSC and significantly higher in BD þ ADMSC than in BD þ ECSW þ ADMSC (Fig. 7) .
ECSW-ADMSC Therapy Suppressed Brain Edema and Inflammatory Biomarkers in Brain Damaged Area by 6 Hours After BD
IF microscopy demonstrated that the cellular infiltrations of GFAP, a component of glial cell in response to brain damage, infection and inflammation, and AQP4, a brain-edema marker (20, 29) , were highest in BD, significantly higher in BD þ ECSW than in BD þ ADMSC and BD þ ECSW þ ADMSC, and significantly (Fig. 8) .
ECSW-ADMSC Therapy Suppressed DNADamaged Marker and Preserved Neurons in Brain Damaged Area by 6 Hours After BD IF microscopic finding showed that the cellular expression of c-H2AX, an indicator of DNA-damaged marker, was highest in BD, significantly higher in BD þ ECSW than in BD þ ADMSC and BD þ ECSW þ ADMSC, and significantly lower in BD þ ADMSC than in BD þ ECSW þ ADMSC. On the other hand, the positively stained NeuN in brain tissue, an indicator of neurons exhibited an opposite pattern of c-H2AX among the 5 groups (Fig. 9) .
ECSW-ADMSC Therapy Suppressed Cellular
Expressions of CD11b and Iba-1 in Brain Damaged Area by 6 Hours After BD Microscopic finding showed that the cellular expressions of CD11b and Ib-a1, 2 indicators of inflammatory biomarkers, were highest in BD, significantly higher in BD þ ECSW than in BD þ ADMSC and BD þ ECSW þ ADMSC, and significantly lower in BD þ ADMSC than in BD þ ECSW þ ADMSC (Fig. 10) .
DISCUSSION
This study investigated the therapeutic impact of ECSW-ADMSC on protecting the brain against BD-induced injury and yielded several striking implications. First, the experimental study demonstrated that BD not only elicited localized inflammation and generation of oxidative stress but also augmented circulating levels of inflammatory immune reactions. Second, either ECSW or ADMSC therapy were comparable for attenuating local (within the brain organ) and systemic (peripheral blood and spleen) inflammatory immune reactions. Third, of particular importance was that combined ECSW-ADMSC was superior to either one alone for suppressing inflammatory immune reactions in both local and circulating systems.
Previous studies (12) (13) (14) (15) have shown that up to 25% of heart function was injured even during the early stages of BD (16) , implicating acute inflammatory immune reactions (17) (18) (19) (20) (21) . Of importance in the present study, even within a short time (6-hour study period) after BD induction, oxidative stress and inflammatory immune reactions were markedly increased both in the locally damaged zone (i.e. in the brain tissue) and remotely (in the circulation and spleen). Accordingly, our findings support those of previous studies (16) (17) (18) (19) (20) (21) and confirm successful creation of a reliable BD experimental model for study.
Our previous study demonstrated that ECSW therapy significantly improved neurological function and reduced brain infarct volume in rat after acute ischemic stroke mainly through inhibition of inflammation, oxidative stress and cellular apoptosis (29) . An essential finding in the present study was that, as compared with BD animals, ECSW therapy suppressed the inflammatory immune reaction, oxidative stress and apoptosis, and reduced mitochondrial damage in brain. In this way, our findings were consistent with those of our previous study (29) .
Our previous study demonstrated that ADMSC therapy protected the BD donor heart against postheart transplant acute rejection (20) . Our study has further demonstrated that the mechanism underlying how AMDMS therapy reduced the incidence of graft-versus-host disease was via immunomodulating and inhibiting the inflammatory reaction (20) . A principal finding in the present study was that, as compared with BD animals, the cellular-molecular perturbations (i.e. inflammatory immune reactions, generation of oxidative stress, apoptosis, mitochondrial/DNA damage biomarkers) were substantially reduced in BD animals after receiving ADMSC treatment. These findings corroborated those of our previous study (20) .
The most important finding in the present study was that combined ECSW-ADMSC therapy was superior to either one alone at suppressing molecular-cellular perturbations and upregulating protein expression of antioxidants in BD animals, highlighting that this was an additional benefit of combining these 2 regimens mainly through anti-inflammation (offered by ECSW/ADMSC) and immunomodulation (offered by ADMSC).
Study Limitation
This study has limitations. First, the study period was relatively short (i.e. only 6 hours duration) so the long-term effect of ECSW-ADMSC therapy remains uncertain. Second, for the same reason, we do not know whether the animals could recover from the BD scenario.
In conclusion, ECSW-ADMSC therapy effectively protected the brain from BD-induced damage by suppressing inflammatory immune reactions and attenuating the generation of oxidative stress and apoptosis.
